Blue Ocean Health, the integrated healthcare platform behind Fakih IVF Fertility Group, First Genomics, First Compounding ...

CMH’s Community Grants and Sponsorships Program revamped As of January, Columbia Memorial Hospital’s Community Sponsorships and Grants Program has two deadlines to apply each year, March 31 and Sept ...

Online sales of unapproved peptides are booming, and patients injecting these drugs are increasingly presenting to EDs with ...

Raelynn Davis, 15, has aspirations of earning a Doctor of Pharmacy degree with a goal of becoming a licensed pharmacist.

The Ministry of Health’s First Quarter Budget Performance Report for the 2026/27 financial year shows a surge of about 30 per ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US regulator ...

Peptide boom healthcare leaders face an FDA advisory vote on July 23-24 that could reshape compounding rules for seven key peptides.

Marketed for longevity and wellness benefits, the unproven therapies are sold through a grey market online. Compounding ...

Q: I’m looking for innovative ways to control my blood pressure. I’m avoiding salt and most alcohol, but I need more help to ...

The Elsevier Foundation and The Lancet announced today the three winning teams of the inaugural edition of The Lancet-Elsevier Foundation Evidence to Impact Awards. The Awards recognize research teams ...

The FDA shortage designations that let compounding pharmacies mass-produce copies of semaglutide and tirzepatide have c ...